AMRX·03168L105·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-Activist
AMRX (AMNEAL PHARMACEUTICALS INC) is held by 147 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($304.8M), STATE STREET CORP ($84.5M), DIMENSIONAL FUND ADVISORS LP ($70.7M). Net institutional sentiment: Mixed.
Showing 1-20 of 164
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer